JP2008513427A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513427A5
JP2008513427A5 JP2007531832A JP2007531832A JP2008513427A5 JP 2008513427 A5 JP2008513427 A5 JP 2008513427A5 JP 2007531832 A JP2007531832 A JP 2007531832A JP 2007531832 A JP2007531832 A JP 2007531832A JP 2008513427 A5 JP2008513427 A5 JP 2008513427A5
Authority
JP
Japan
Prior art keywords
pharmacology
medicament
inhibition
diseases
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007531832A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513427A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2005/003584 external-priority patent/WO2006032852A1/en
Publication of JP2008513427A publication Critical patent/JP2008513427A/ja
Publication of JP2008513427A5 publication Critical patent/JP2008513427A5/ja
Withdrawn legal-status Critical Current

Links

JP2007531832A 2004-09-20 2005-09-19 炎症の治療に有用なピラゾール化合物 Withdrawn JP2008513427A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61095204P 2004-09-20 2004-09-20
PCT/GB2005/003584 WO2006032852A1 (en) 2004-09-20 2005-09-19 Pyrazole compounds useful uin the treatment of inflammation

Publications (2)

Publication Number Publication Date
JP2008513427A JP2008513427A (ja) 2008-05-01
JP2008513427A5 true JP2008513427A5 (https=) 2008-11-20

Family

ID=34956280

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007531832A Withdrawn JP2008513427A (ja) 2004-09-20 2005-09-19 炎症の治療に有用なピラゾール化合物

Country Status (4)

Country Link
US (1) US20080090836A1 (https=)
EP (1) EP1794130A1 (https=)
JP (1) JP2008513427A (https=)
WO (1) WO2006032852A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006032851A1 (en) * 2004-09-20 2006-03-30 Biolipox Ab Pyrazole compounds useful in the treatment of inflammation
TW200800911A (en) * 2005-10-20 2008-01-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
EP1943234A1 (en) * 2005-10-31 2008-07-16 Biolipox AB Triazole compounds as lipoxygenase inhibitors
TW200732320A (en) * 2005-10-31 2007-09-01 Biolipox Ab Pyrazoles useful in the treatment of inflammation
JP2009513692A (ja) * 2005-11-01 2009-04-02 バイオリポックス エービー 炎症の治療に有用なピラゾール化合物
MX342128B (es) * 2008-12-24 2016-09-14 Bial - Portela & C A S A Compuestos farmaceuticos.
GB2497476B (en) * 2010-09-06 2018-01-10 Guangzhou Inst Biomed & Health Amide Compounds
JP6520588B2 (ja) * 2015-09-10 2019-05-29 日本軽金属株式会社 スルホニルブロマイド化合物類の製造方法
EP4028395A4 (en) 2019-10-15 2023-09-13 Trobio Therapeutics Pty Ltd Sulfonamide compounds and the use thereof in the treatment of cancer

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639636B1 (fr) * 1988-11-30 1994-03-04 Novapharme Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
US5464860A (en) * 1988-11-30 1995-11-07 Novapharme N(pyrazol-3-yl) benzamides and pharmaceutical compositions
US5258397A (en) * 1988-11-30 1993-11-02 Novapharme 3-Isoxazoyl derivatives endowed with anticonvulsant activity, procedure for their preparation and their pharmaceutical compositions
FR2662692B1 (fr) * 1990-05-30 1995-04-28 Novapharme Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
US5536727A (en) * 1992-05-20 1996-07-16 Merck & Co., Inc. 17-Ethers and thioethers of 4-aza-steroids
JPH07508039A (ja) * 1992-05-20 1995-09-07 メルク　エンド　カンパニー　インコーポレーテッド ４−アザステロイドのエステル誘導体
US6372770B1 (en) * 1994-10-12 2002-04-16 Euro-Celtique, S.A. Benzoxazoles
US5665737B1 (en) * 1994-10-12 1999-02-16 Euro Celtique Sa Substituted benzoxazoles
US5663357A (en) * 1995-11-22 1997-09-02 Allergan Substituted heteroarylamides having retinoid-like biological activity
AUPP042397A0 (en) * 1997-11-18 1997-12-11 Fujisawa Pharmaceutical Co., Ltd. 5-arylpyrazole compounds
ES2316383T3 (es) * 1999-09-17 2009-04-16 Millennium Pharmaceuticals, Inc. Benzamidas e inhibidores relacionados del factor xa.
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
GB0002666D0 (en) * 2000-02-04 2000-03-29 Univ London Blockade of voltage dependent sodium channels
WO2001058869A2 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
KR20030030029A (ko) * 2000-09-22 2003-04-16 니혼노야쿠가부시키가이샤 Ｎ-(4-피라졸릴)아미드 유도체 및 농원예용 약제 그리고그 사용방법
JP4465133B2 (ja) * 2001-02-08 2010-05-19 クミアイ化学工業株式会社 イソオキサゾリン誘導体及びこれを有効成分とする除草剤
WO2003037274A2 (en) * 2001-11-01 2003-05-08 Icagen, Inc. Pyrazole-amides and-sulfonamides
US7016421B2 (en) * 2001-11-15 2006-03-21 Hrl Laboratories, Llc Time-interleaved delta sigma analog to digital modulator
TWI263497B (en) * 2002-03-29 2006-10-11 Lilly Co Eli Pyridinoylpiperidines as 5-HT1F agonists
WO2004039795A2 (en) * 2002-10-29 2004-05-13 Fujisawa Pharmaceutical Co., Ltd. Amide compounds for the treatment of hyperlipidemia
AU2003286876A1 (en) * 2002-11-01 2004-06-07 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of jak and other protein kinases
EP1571671A4 (en) * 2002-12-13 2008-04-02 Matsushita Electric Industrial Co Ltd OPTICAL DATA DISTRIBUTION EQUIPMENT
US7429581B2 (en) * 2002-12-23 2008-09-30 Sanofi-Aventis Deutschland Gmbh Pyrazole-derivatives as factor Xa inhibitors
WO2004080999A1 (en) * 2003-03-14 2004-09-23 Biolipox Ab Pyrazole compounds useful in the treatment of inflammation
SE0300705D0 (sv) * 2003-03-14 2003-03-14 Biolipox Ab New compounds
MXPA05011503A (es) * 2003-04-25 2006-05-31 Johnson & Johnson Inhibidores de la c-fms cinasa.

Similar Documents

Publication Publication Date Title
ECSP088902A (es) Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
EP2639229A3 (en) Thiazole Derivative and use thereof as VAP-1 Inhibitor
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
JP2006502236A5 (https=)
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
MY148108A (en) Medicaments for the treatment or prevention of fibrotic diseases
EP2620145A3 (en) 2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ
JP2003503454A5 (https=)
NO20084502L (no) Tetrahydropyrrolopyrimidinedioner og deres anvendelse som humane neutrofil elastase inhibitorer
EA201001669A1 (ru) Замещенные пиримидин-5-карбоксамиды 281
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
JP2007520565A5 (https=)
DK2173749T3 (da) 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydro-indolizin-3-yl)-acetamidderivater og beslægtede forbindelser som antisvampemidler
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
JP2008513426A5 (https=)
JP2008513510A5 (https=)
JP2003526626A5 (https=)
JP2006514116A5 (https=)
JP2004002446A5 (https=)
PL2422786T3 (pl) Nowe kombinacje środków leczniczych do leczenia chorób dróg oddechowych
WO2007046867A3 (en) Piperidine derivatives and their uses as therapeutic agents
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
NO20083790L (no) Nye terapeutiske kombinasjoner for behandling eller forebygging av psykotiske lidelser
JP2008513427A5 (https=)